rs4722758

This variant is located in the JAZF1 gene.

GWAS Catalog Trait Associations (6)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

lymphocyte count

Sakaue S et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nature Genetics 53(10):1415-1424 (2021)
Allele G
OR 0.03
p 2.0e-22
N 445,573
Large GWAS
multi-ancestry

tyrosine measurement

Karjalainen MK et al. Genome-wide characterization of circulating metabolic biomarkers. Nature 628(8006):130-138 (2024)
Allele C
OR 0.05
p 2.0e-21
N 136,016
Large GWAS
multi-ancestry

lymphocyte percentage of leukocytes

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele G
OR 0.03
p 1.0e-19
N 408,112
Large GWAS
European

asthma

Ferreira MAR et al. Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct. American Journal of Human Genetics 104(4):665-684 (2019)
Allele G
OR 1.08
p 6.0e-18
N 341,215
Large GWAS
European
Allele G
OR
p 4.0e-14
N 281,699
Major Consortium StudyLarge GWAS
European

asthma, Eczematoid dermatitis, allergic rhinitis

Allele G
OR 1.06
p 2.0e-16
N 346,545
Major Consortium StudyLarge GWAS
European

neutrophil percentage of leukocytes

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele G
OR 0.02
p 1.0e-9
N 408,112
Large GWAS
European

About JAZF1

This gene encodes a nuclear protein with three C2H2-type zinc fingers, and functions as a transcriptional repressor. Chromosomal aberrations involving this gene are associated with endometrial stromal tumors. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized [provided by RefSeq, Jul 2008]

View all JAZF1 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…